Evaluation of N-substituent structural variations in opioid receptor profile of LP1
- 1 June 2016
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 24 (12) , 2832-2842
Abstract
No abstract availableKeywords
Funding Information
- Sixth Framework Programme (LSHC-CT-2006-037733)
This publication has 38 references indexed in Scilit:
- Multitarget opioid ligands in pain relief: New players in an old gameEuropean Journal of Medicinal Chemistry, 2016
- Pharmacological Investigations of N-Substituent Variation in Morphine and Oxymorphone: Opioid Receptor Binding, Signaling and Antinociceptive ActivityPLOS ONE, 2014
- Opiate Pharmacology and Relief of PainJournal of Clinical Oncology, 2014
- The µ Opioid Receptor and Ligands Acting at the µ Opioid Receptor, as Therapeutics and Potential TherapeuticsCurrent Pharmaceutical Design, 2014
- Mu Opioids and Their Receptors: Evolution of a ConceptPharmacological Reviews, 2013
- The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: BenzomorphansBioorganic & Medicinal Chemistry, 2008
- Bremazocine: A κ‐Opioid Agonist with Potent Analgesic and Other Pharmacologic PropertiesCNS Drug Reviews, 2005
- Mu opioid receptor: a gateway to drug addictionCurrent Opinion in Neurobiology, 2004
- Analgesic activity of a novel use‐dependent sodium channel blocker, crobenetine, in mono‐arthritic ratsBritish Journal of Pharmacology, 2001
- Synthesis and in Vitro and in Vivo Activity of (−)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-Alkenyl-, -N-Alkynyl-, and -N-Cyanoalkyl-5,9-dimethyl-2‘-hydroxy-6,7-benzomorphan HomologuesJournal of Medicinal Chemistry, 2000